Suppr超能文献

腮腺多形性腺瘤中INK4a-ARF基因座的改变。

Alterations of the INK4a-ARF gene locus in pleomorphic adenoma of the parotid gland.

作者信息

Weber Anette, Langhanki Larissa, Schütz Alexander, Wittekind Christian, Bootz Friedrich, Tannapfel Andrea

机构信息

Department of Otorhinolaryngology, Head and Neck Surgery, University of Leipzig, Liebigstrasse 18a, Germany.

出版信息

J Pathol. 2002 Nov;198(3):326-34. doi: 10.1002/path.1210.

Abstract

Pleomorphic adenomas of the parotid gland are benign tumours composed of epithelial and mesenchymal cells. The INK4a-ARF (CDKN2A) locus on chromosome 9p21 encodes two tumour suppressor proteins, p16(INK4a) and p14(ARF), which act as upstream regulators of the Rb-CDK4 and p53 pathways. To study the contribution of each pathway in pleomorphic adenomas, this study analysed alterations of p14(ARF), p16(INK4a), p53, and pRb in these tumours. After microdissecting the different histological components, 42 pleomorphic adenomas of the parotid gland were analysed for INK4a-ARF inactivation by DNA sequence analysis, methylation-specific PCR (MSP), restriction enzyme-related polymerase chain reaction (RE-PCR), mRNA expression, microsatellite analysis, and immunohistochemistry. In addition, microdeletion of p14(ARF) and p16(INK4a) were assessed by differential PCR. The status of p53 and Rb was examined by direct sequencing and immunohistochemistry. Using microdissection, it was possible to examine the tumour components, i.e. epithelial, mesenchymal, and transitional, separately after immunohistochemical identification. Methylation of p14(ARF) was found in 1/42 cases and alterations of p16(INK4a) occurred in 12/42 of pleomorphic adenomas, which correlated with loss of mRNA transcription. Microdeletions or specific mutations of either exon were not detected. Methylation was detected exclusively in the epithelial and transitional components and not within the mesenchymal part of the tumour. p53 mutations were detected in 4/42 adenomas, also occurring solely in the epithelial components of the tumours. pRb was detected immunohistochemically in 40/42 adenomas. In normal, corresponding parotid tissue, p14(ARF), p16(INK4a), p53, and pRb alterations were not observed. The observation that alterations of p14(ARF) and p16(INK4a), and also p53 mutations, occurred exclusively in the epithelial and transitional components of pleomorphic adenoma supports the theory that these areas are prone to malignant transformation to carcinoma in adenoma.

摘要

腮腺多形性腺瘤是由上皮细胞和间充质细胞组成的良性肿瘤。位于9号染色体p21上的INK4a-ARF(CDKN2A)基因座编码两种肿瘤抑制蛋白,即p16(INK4a)和p14(ARF),它们作为Rb-CDK4和p53通路的上游调节因子。为了研究每条通路在多形性腺瘤中的作用,本研究分析了这些肿瘤中p14(ARF)、p16(INK4a)、p53和pRb的改变。在对不同组织学成分进行显微切割后,通过DNA序列分析、甲基化特异性PCR(MSP)、限制性内切酶相关聚合酶链反应(RE-PCR)、mRNA表达、微卫星分析和免疫组织化学,对42例腮腺多形性腺瘤进行INK4a-ARF失活分析。此外,通过差异PCR评估p14(ARF)和p16(INK4a)的微缺失情况。通过直接测序和免疫组织化学检测p53和Rb的状态。利用显微切割技术,在免疫组织化学鉴定后,可以分别检查肿瘤成分,即上皮、间充质和过渡成分。在42例病例中有1例发现p14(ARF)甲基化,42例多形性腺瘤中有12例发生p16(INK4a)改变,这与mRNA转录缺失相关。未检测到外显子的微缺失或特定突变。甲基化仅在上皮和过渡成分中检测到,而在肿瘤的间充质部分未检测到。在42例腺瘤中有4例检测到p53突变,也仅发生在肿瘤的上皮成分中。在42例腺瘤中有40例通过免疫组织化学检测到pRb。在正常的相应腮腺组织中,未观察到p14(ARF)、p16(INK4a)、p53和pRb的改变。p14(ARF)和p16(INK4a)的改变以及p53突变仅发生在多形性腺瘤的上皮和过渡成分中的观察结果支持了这些区域易于向腺瘤性癌恶性转化的理论。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验